Paediatric Consumer Health in Uruguay

Abstract
In 2022. paediatric analgesics continued to account for the highest proportion of retail current value sales in paediatric consumer health in Uruguay. While paediatric aspirin dominates retail volume sales, paediatric ibuprofen still accounts the majority of retail current value sales of analgesics, distantly followed by paediatric acetaminophen and paediatric aspirin. As in 2020 and 2021, acetaminophen posted dynamic retail volume and current value growth in 2022, having benefitted from initial...

Euromonitor International's Paediatric Consumer Health in Uruguay report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2017-2021, allowing you to identify the sectors driving growth. Forecasts to 2026 illustrate how the market is set to change.

Product coverage: Nappy (Diaper) Rash Treatments, Paediatric Analgesics, Paediatric Cough, Cold and Allergy Remedies, Paediatric Dermatologicals, Paediatric Digestive Remedies, Paediatric Vitamins and Dietary Supplements.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Paediatric Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Content
Paediatric Consumer Health in Uruguay

List Of Contents And Tables

PAEDIATRIC CONSUMER HEALTH IN URUGUAY
KEY DATA FINDINGS
2022 DEVELOPMENTS
Government recommendation continues to support strong performance by paediatric acetaminophen
Bayer SA Uruguay’s Supradyn Infantil continues to benefit from COVID-19-related demand
PROSPECTS AND OPPORTUNITIES
Positive growth expected, with paediatric acetaminophen vitamins and dietary supplements set to lead the way
Demand for value-priced generic brands set to increase over the forecast period
Healthier eating habits pose a hurdle to growth over the forecast period
CATEGORY DATA
Table 1 Sales of Paediatric Consumer Health by Category: Value 2017-2022
Table 2 Sales of Paediatric Consumer Health by Category: % Value Growth 2017-2022
Table 3 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2017-2022
Table 4 Forecast Sales of Paediatric Consumer Health by Category: Value 2022-2027
Table 5 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2022-2027
CONSUMER HEALTH IN URUGUAY
EXECUTIVE SUMMARY
Consumer health in 2022: The big picture
2022 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 6 Consumer Expenditure on Health Goods and Medical Services: Value 2017-2022
Table 7 Life Expectancy at Birth 2017-2022
MARKET DATA
Table 8 Sales of Consumer Health by Category: Value 2017-2022
Table 9 Sales of Consumer Health by Category: % Value Growth 2017-2022
Table 10 NBO Company Shares of Consumer Health: % Value 2018-2022
Table 11 LBN Brand Shares of Consumer Health: % Value 2019-2022
Table 12 Distribution of Consumer Health by Format: % Value 2017-2022
Table 13 Distribution of Consumer Health by Format and Category: % Value 2022
Table 14 Forecast Sales of Consumer Health by Category: Value 2022-2027
Table 15 Forecast Sales of Consumer Health by Category: % Value Growth 2022-2027
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources